TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State February 14, 1997
TCL Archive In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office July 20, 1990